4.7 Article

Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery Miniperspective

Related references

Note: Only part of the references are listed.
Review Cell Biology

Malaria parasite egress at a glance

Michele S. Y. Tan et al.

Summary: All intracellular pathogens, including the malaria parasite, must escape from the host cell to proliferate. The process of egress in the Plasmodium life cycle occurs at four distinct phases, involving disruption of membranes or cyst walls in a regulated manner. Researchers are studying the morphological features and molecular mechanisms of egress to develop new approaches for malaria control.

JOURNAL OF CELL SCIENCE (2021)

Article Chemistry, Medicinal

The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities

Marco Robello et al.

Summary: Researchers have utilized the α-ketoamide motif to design innovative hit/lead molecules tailored to a variety of biological targets, showing clinical potential for treating various pathological conditions. This perspective provides insights into the versatility of this chemical moiety as a privileged structure in drug discovery, highlighting its application as either a nonreactive or reactive moiety in compound design.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1

Elina Lidumniece et al.

Summary: Malaria is a devastating infectious disease causing over 400,000 deaths annually. Researchers have developed substrate-based peptidic boronic acids that inhibit a parasite protease called SUB1, preventing parasite replication through egress and potentially serving as a new class of antimalarial drugs.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Chemistry, Medicinal

Design and discovery of boronic acid drugs

Jessica Plescia et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Will morphing boron-based inhibitors beat the β-lactamases?

Alen Krajnc et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2019)

Review Infectious Diseases

Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!

Christian Nsanzabana

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2019)

Review Microbiology

Targeting malaria parasite invasion of red blood cells as an antimalarial strategy

Amy L. Burns et al.

FEMS MICROBIOLOGY REVIEWS (2019)

Article Chemistry, Medicinal

Semisynthesis, cytotoxicity, antimalarial evaluation and structure-activity relationship of two series of triterpene derivatives

Simone Tasca Cargnin et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Review Infectious Diseases

New developments in anti-malarial target candidate and product profiles

Jeremy N. Burrows et al.

MALARIA JOURNAL (2017)

Review Chemistry, Multidisciplinary

The versatility of boron in biological target engagement

Diego B. Diaz et al.

NATURE CHEMISTRY (2017)

Article Chemistry, Organic

Quinoxaline-Based Inhibitors of Malarial Protease PfSUB1

S. S. Kher et al.

CHEMISTRY OF HETEROCYCLIC COMPOUNDS (2015)

Article Chemistry, Medicinal

Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1

Samir S. Kher et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)

Article Chemistry, Medicinal

Rational design of the first difluorostatone-based PfSUB1 inhibitors

Simone Giovani et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)

Review Biochemistry & Molecular Biology

Boronic Acid-based Enzyme Inhibitors: A Review of Recent Progress

H. Fu et al.

CURRENT MEDICINAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

A novel Plasmodium-specific prodomain fold regulates the malaria drug target SUB1 subtilase

David Giganti et al.

NATURE COMMUNICATIONS (2014)

Article Multidisciplinary Sciences

The malaria parasite egress protease SUB1 is a calcium-dependent redox switch subtilisin

Chrislaine Withers-Martinez et al.

NATURE COMMUNICATIONS (2014)

Article Chemistry, Medicinal

Molecular Determinants of Binding to the Plasmodium Subtilisin-like Protease 1

Simone Fulle et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)

Article Chemistry, Medicinal

Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1

Sandra Gemma et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Biochemistry & Molecular Biology

Multi-targeted activity of maslinic acid as an antimalarial natural compound

Carlos Moneriz et al.

FEBS JOURNAL (2011)

Article Biochemistry & Molecular Biology

Subtilases: The superfamily of subtilisin-like serine proteases

Roland J. Siezen et al.

PROTEIN SCIENCE (2010)

Article Biochemistry & Molecular Biology

A multifunctional serine protease primes the malaria parasite for red blood cell invasion

Konstantinos Koussis et al.

EMBO JOURNAL (2009)

Article Biochemistry & Molecular Biology

Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum

Shirin Arastu-Kapur et al.

NATURE CHEMICAL BIOLOGY (2008)